M. Y. KÖKER Et Al. , "New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains," Platelets , vol.33, no.4, pp.551-561, 2022
KÖKER, M. Y. Et Al. 2022. New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains. Platelets , vol.33, no.4 , 551-561.
KÖKER, M. Y., SARPER, N., Albayrak, C., ZÜLFİKAR, O. B., ZENGİN, E., SARAYMEN, B., ... Albayrak, D.(2022). New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains. Platelets , vol.33, no.4, 551-561.
KÖKER, MUSTAFA Et Al. "New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains," Platelets , vol.33, no.4, 551-561, 2022
KÖKER, MUSTAFA Y. Et Al. "New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains." Platelets , vol.33, no.4, pp.551-561, 2022
KÖKER, M. Y. Et Al. (2022) . "New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains." Platelets , vol.33, no.4, pp.551-561.
@article{article, author={MUSTAFA YAVUZ KÖKER Et Al. }, title={New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains}, journal={Platelets}, year=2022, pages={551-561} }